Proto-oncogene Wip1, a member of a new family of proliferative genes in NSCLC and its clinical significance

Tumor Biology

Volumn 35, Issue 4, 2014, Pages 2975-2981

  Fu, Zhanzhao ^a   Sun, Guogui ^a,b   Gu, Tao ^a  

^a The First Hospital of Qinhuangdao   (China)

^b TANGSHAN PEOPLE S HOSPITAL   (China)

Author keywords

Immunohistochemistry; NSCLC carcinoma; Reverse transcription polymerase chain reaction; Western blot; Wip1

Indexed keywords

LIPOSOME; MESSENGER RNA; SMALL INTERFERING RNA;

ADULT; AGED; APOPTOSIS; ARTICLE; BIOLOGICAL PHENOMENA AND FUNCTIONS CONCERNING THE ENTIRE ORGANISM; CELL CYCLE; CELL PROLIFERATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTO ONCOGENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR DIFFERENTIATION; TUMOR VOLUME; WESTERN BLOTTING; WILD TYPE P53 INDUCED PHOSPHATASE 1 PROTO ONCOGENE; YOUNG ADULT;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; CELL PROLIFERATION; FEMALE; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; PHOSPHOPROTEIN PHOSPHATASES; PROGNOSIS;

EID: 84898816323     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-1382-y     Document Type: Article

References (19)

1. Sculier JP. Non small cell lung cancer. Eur Respir Rev. 2013;22:33-6.
2. Sculier JP, Berghmans T, Meert AP. Thoracic oncology: annual review. Rev Med Brux. 2013;34:100-11.
3. Fuku T, Semba S, Yutori H, Yokozaki H. Increased wild-type p53-induced phosphatase 1 (Wip1 or PPM1D) expression correlated with downregulation of checkpoint kinase 2 in human gastric carcinoma. Pathol Int. 2007;57:566-71.
4. Li J, Yang Y, Peng Y, Austin RJ, van Eyndhoven WG, Nguyen KC, et al. Oncogenic properties of PPM1D located within a breast cancer amplification epicenter at 17q23. Nat Genet. 2002;31:133-4.
5. Saito-Ohara F, Imoto I, Inoue J, Inoue J, Hosoi H, Nakagawara A, et al. PPM1D is a potential target for 17q gain in neuroblastoma. Cancer Res. 2003;63:1876-83.
6. Mendrzyk F, Radlwimmer B, Joos S, Kokocinski F, Benner A, Stange DE, et al. Economic and protein expression profiling identifies CDK6 as novel in dependent prognostic marker in medulloblastoma. J Clin Oncol. 2005;23:8853-62.
7. Yang DH, He JA, Li J, Ma WF, Hu XH, Xin SJ, et al. Expression of proto-oncogene Wip1 in breast cancer and its clinical significance. Natl Med J Chin. 2010;90:519-22.
8. Ling CH, Jiao BH, Lu SK, Guo EK, Zhang GY. The expression of proto-oncogene Wip1 in human glioblastoma multiforme and cell lines. Chin J Neuro-Oncol. 2011;9:1-6.
9. Ling CH, Jiao BH, Guo EK, Lu SK. Overexpression of proto-oncogene Wip1 in intracranial ependymomas association with P53. Basic Clin Med. 2011;31:430-4.
10. Yang DH, Zhang H, Hu XH, Xin SJ, Duan ZQ. Abnormality of p16/p38MAPK/p53/Wip1 pathway in papillary thyroid cancer and its significance. Chin J Gen Surg. 2011;20:1199-202.
11. Oliva TM, Berthonaud V, Chevalier A, Ducrot C, Marsolier-Kergoat MC, Mann C, et al. The Wip1 phosphatase (PPM1D) antagonizes activation of the Chk2 tumor suppressor kinase. Oncogene. 2007;26:1449-58.
12. Goldstraw P, Ball D, Jett JR, Le Chevalier T, Lim E, Nicholson AG, et al. Non small cell lung cancer. Lancet. 2011;378:1727-40.
13. Reck M, Heigener DF, Mok T, Soria JC, Rabe KF. Management of non small cell lung cancer: recent developments. Lancet. 2013;382:709-19.
14. Tsim S, O'Dowd CA, Milroy R, Davidson S. Staging of non small cell lung cancer (NSCLC): a review. Respir Med. 2010;104:1767-74.
15. Wang P, Rao J, Yang HF, Zhao HY, Yang L. Inhibitory effects of lentivirus mediated RNA interference targeting human Wip1 gene on the proliferation of human glioma U251 cells. Chin J Exp Surg. 2010;27:76-9.
16. Baxter EW, Milner J. p53 Regulates LIF expression in human medulloblastoma cells. J Neurooncol. 2010;97:373-82.
17. Lowe JM, Cha H, Yang Q, Fornace Jr AJ. Nuclear factor-kappaB (NF-kappaB) is a novel positive transcriptional regulator of the oncogenic Wip1 phosphatase. J Biol Chem. 2010;285:5249-57.
18. Armstrong NJ, Fagotto F, Pthmann C, Rupp RA. Maternal Wnt/β-catenin signaling coactivates transcription through NF-κB binding sites during Xenopus axis formation. PLoS One. 2012;7:e36136.
19. Pan H, Zhou W, He W, Liu X, Ding Q, Ling L, et al. Genistein inhibits MDA-MB-231 triple-negative breast cancer cell growth by inhibiting NF-kappaB activity via the Notch-1 pathway. Int J Mol Med. 2012;30:337-43.